Cardiotoxin-I: an unexpectedly potent insulinotropic agent.
about
Peptide Fraction pOh2 Exerts Antiadipogenic Activity through Inhibition of C/EBP-α and PPAR-γ Expression in 3T3-L1 Adipocytes.Investigational insulin secretagogues for type 2 diabetes.Snake venom toxins: toxicity and medicinal applications.Revisiting the Therapeutic Potential of Bothrops jararaca Venom: Screening for Novel Activities Using Connectivity Mapping.
P2860
Cardiotoxin-I: an unexpectedly potent insulinotropic agent.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Cardiotoxin-I: an unexpectedly potent insulinotropic agent.
@en
Cardiotoxin-I: an unexpectedly potent insulinotropic agent.
@nl
type
label
Cardiotoxin-I: an unexpectedly potent insulinotropic agent.
@en
Cardiotoxin-I: an unexpectedly potent insulinotropic agent.
@nl
prefLabel
Cardiotoxin-I: an unexpectedly potent insulinotropic agent.
@en
Cardiotoxin-I: an unexpectedly potent insulinotropic agent.
@nl
P2093
P2860
P356
P1433
P1476
Cardiotoxin-I: an unexpectedly potent insulinotropic agent.
@en
P2093
Alain Fournier
David Chatenet
Myriam Létourneau
Nam Hai Truong
Nicolas Doucet
Thi Tuyet Nhung Nguyen
P2860
P304
P356
10.1002/CBIC.201200081
P577
2012-07-16T00:00:00Z